Azman Ali Raymond

Azman Ali Raymond

Auto-generated profile, based on publicly available information

Azman Ali Raymond

Department of Medicine Faculty of Medicine, UiTM, Sungai Buloh Campus Selangor Malaysia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2020 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
APALVIN OLIVER PAYUS
ALVIN OLIVER PAYUS
CLConstance Sat Lin Liew
Constance Sat Lin Liew
MNMalehah Mohd Noh
Malehah Mohd Noh
MJMohammad Saffree Jeffree
Mohammad Saffree Jeffree
RARaymond Azman Ali
Raymond Azman Ali
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is believed to have emerged from an animal source and has been spreading rapidly among humans. Recent evidence shows that SARS-CoV-2 exhibits neurotropic properties and causes neurological diseases. Here, we review the literature on neurological involvement in SARS-CoV-2 infections and the possible mechanisms of invasion of the nervous system by this virus, to provide a summary and critical analysis of the early reporting of neurological involvement in COVID-19. An exhaustive search of scientific articles on neurological involvement in COVID-19 was performed in the Web of Science, Scopus, Medline/PubMed, and several other databases. Nineteen relevant articles that had been published or were in preprint were carefully selected according to the inclusion and exclusion criteria. Based on our research, we found that patients with COVID-19 can present with neurological symptoms that can be broadly divided into central nervous system involvement, such as headache, dizziness, altered mental state, and disorientation, and peripheral nervous system involvement, such as anosmia and hypogeusia. Most of these patients are in the older age group and exhibit comorbidities, especially hypertension, and severe infection. In extreme presentations of COVID-19, some patients exhibit seizures, stroke, flaccid paraparesis, corticospinal weakness, and even coma. Moreover, the neurological man­ifestations can occur independently of the respiratory system. In conclusion, SARS-CoV-2 infection can cause multiple neurological syndromes in a more complex presentation. Therefore, this review elucidated the involvement of the nervous system in SARS-CoV-2 infection and will hopefully help improve the management of COVID-19.

13 March 2014 in Pharmacogenomics
Verified
Journal Article
Closed access
HSHidayati Mohd Sha‘ari
Hidayati Mohd Sha‘ari
BHBatoul Sadat Haerian
Batoul Sadat Haerian
Larry BaumLarry Baum
Larry Baum
JSJunji Saruwatari
Junji Saruwatari
HTHui Jan Tan
Hui Jan Tan
ZMZahurin Mohamed
Zahurin Mohamed
To examine the relevance of ABCC2 polymorphisms to drug responsiveness in epilepsy cohorts from the Asia Pacific region. The rs2273697 and rs3740066 polymorphisms were genotyped in 2056 Malaysian (55%), Hong Kong (32%) and Japanese (13%) epilepsy patients. Significant allele association of rs2273697 was observed in Chinese females with epilepsy, Malaysian Chinese patients with generalized seizure and Japanese patients with partial seizure for the AA versus GG genotype model and Malaysian Chinese patients with generalized seizure for the GA versus GG and autosomal dominant models. Significant association of the rs3740066 allele was observed in Malaysian females of Malay origin with cryptogenic epilepsy and Chinese patients with partial seizure and for genotypes in Malay patients with cryptogenic epilepsy for the CT versus CC and autosomal dominant genotype models. Significant results were observed for all haplotypes, but following Bonferroni correction, only the GT haplotype in Chinese patients remained significant. This study suggests that the GT haplotype might be a risk factor for resistance to medication in Chinese patients.

1 October 2020 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
APAlvin Oliver Payus
Alvin Oliver Payus
CCClarita Clarence
Clarita Clarence
RARaymond Azman Ali
Raymond Azman Ali
Group B streptococcus (GBS) is a rare cause of meningitis in adults that commonly affects patients with multiple underlying comorbidities. Although it is uncommon, it typically progresses very rapidly and has a high mortality rate as compared to other causes of bacterial meningitis. Here, we report a patient with GBS meningitis who had no underlying medical illness and presented with multiple episodes of seizure within hours of developing fever. Cerebrospinal fluid analysis results were consistent with bacterial meningitis, and blood cultures grew GBS. She was treated with intravenous ceftriaxone for 2 weeks and made a great recovery without any sequalae. In conclusion, although GBS meningitis is uncommon in adults, it is a serious medical disease and associated with a high mortality rate. To the best of our knowledge, this patient represents one of the few reported cases of GBS meningitis in a previously healthy young adult.

2 February 2026 in Epileptic Disorders
Verified
Journal Article
Closed access
MOMarjorie Jia Yi Ong
Marjorie Jia Yi Ong
MRMuhammad Samir Haziq Abd Rahman
Muhammad Samir Haziq Abd Rahman
CCCarmen Jia Yinn Chang
Carmen Jia Yinn Chang
ZWZhi Wen Wong
Zhi Wen Wong
WWWen Hui Wee
Wen Hui Wee
ASAdam Strzelczyk
Adam Strzelczyk

1 January 2024 in Case Reports in Neurological Medicine
Verified
Journal Article
Open access
CPChun seng Phua
Chun seng Phua
ARAzman Ali Raymond
Azman Ali Raymond
SBShalini Bhaskar
Shalini Bhaskar
An 18‐year‐old male presented with new‐onset focal to bilateral tonic‐clonic seizures 5 days after receiving the first dose of COVID‐19 vaccine. 3 days later, an identical seizure occurred lasting 1 min, leading to an acute presentation to the hospital. In hospital, the patient was loaded with intravenous phenytoin and started on levetiracetam with no further seizure recurrence. CT venogram and scalp EEG were unremarkable. MRI brain revealed generalised atrophy with mild bilateral hippocampal atrophy. The patient was maintained on 500 mg levetiracetam twice daily and advised to proceed with subsequent doses of vaccination. Vaccinations have been associated with breakthrough seizures. In this case, COVID‐19 vaccination possibly unmasked an underlying predisposition for epilepsy.

22 June 2023 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
CPChia Yin Por
Chia Yin Por
TLThien Thien Lim
Thien Thien Lim
YCYong Chuan Chee
Yong Chuan Chee
ARAzman Ali Raymond
Azman Ali Raymond
Por CY, et al. J Clin Neurol. 2023 Jul;19(4):410-412. https://doi.org/10.3988/jcn.2023.0009